Invention Publication
- Patent Title: IMPROVED DUAL SPECIFICITY POLYPEPTIDE MOLECULE
-
Application No.: US18331556Application Date: 2023-06-08
-
Publication No.: US20230348598A1Publication Date: 2023-11-02
- Inventor: Martin HOFMANN , Felix UNVERDORBEN , Sebastian BUNK , Dominik MAURER
- Applicant: Immatics Biotechnologies GmbH
- Applicant Address: DE Tuebingen
- Assignee: Immatics Biotechnologies GmbH
- Current Assignee: Immatics Biotechnologies GmbH
- Current Assignee Address: DE Tuebingen
- Priority: DE 2017115966.5 2017.07.14 DE 2017119866.0 2017.08.30 DE 2018108995.3 2018.04.16
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/10 ; C07K16/30 ; C07K16/46

Abstract:
The present invention relates to a bispecific polypeptide molecule comprising a first polypeptide chain and a second polypeptide chain providing a binding region derived from a T cell receptor (TCR) being specific for a major histocompatibility complex (MHC)-associated peptide epitope, and a binding region derived from an antibody capable of recruiting human immune effector cells by specifically binding to a surface antigen of said cells, as well as methods of making the bispecific polypeptide molecule, and uses thereof.
Information query